Sold by: Next Move Strategy Consulting
Deployed on AWS
Access market sizing, forecasts, segmentation, regional analysis, competitive intelligence, and company profiles for the global Vascular Dementia (VaD) Drugs Market, valued at USD 2.9 billion in 2025 and projected to reach USD 3.6 billion by 2030 at a CAGR of 4.3%.
Overview
Vascular Dementia (VaD) Drugs Market Data Product Overview
The Vascular Dementia (VaD) Drugs Market data product covers market sizing, historical and forecast analysis, market segmentation, regional and country-level insights, competitive analysis, key players, strategic developments, growth drivers, restraints, and investment opportunities. The market was valued at USD 2.76 billion in 2024 and is estimated at USD 2.9 billion in 2025, with revenue projected to reach USD 3.6 billion by 2030 at a CAGR of 4.3%. The study analyzes drug class, formulation, route of administration, distribution channel, application, and regional markets, with geographic coverage across 28 countries. The research combines primary interviews with industry experts and secondary research from proprietary databases and industry sources, with findings presented as aggregated market analysis.
Use Cases
-
Market entry sizing: Assess market potential from USD 2.9 billion in 2025 to USD 3.6 billion by 2030, supported by country-level analysis across 28 countries.
-
Therapy portfolio evaluation: Compare cholinesterase inhibitors, NMDA receptor modulators, monoaminergic agents, antipsychotics, antiplatelets, anticoagulants, antihypertensives, and other drug classes.
-
Competitive benchmarking: Evaluate 15 profiled companies and market-share information available for 10 companies across pharmaceutical and biotechnology participants in the vascular dementia treatment landscape.
-
Commercial and channel strategy: Analyze capsule, patch, liquid, and injectable formulations; oral, transdermal, parenteral, subcutaneous, and sublingual routes; and hospital pharmacy, retail pharmacy, and e-commerce distribution channels.
Metadata
Update Frequency: One-time syndicated product
Data Source(s): Primary interviews + secondary research (proprietary databases, industry journals)
Original Publisher of data: Next Move Strategy Consulting
Geographic coverage: 28 countries across North America, Europe, Asia-Pacific, and Rest of the World, including Latin America, Middle East, and Africa, with country-level analysis
Time period coverage: 2024–2030
Is historical data "point-in-time": Historical figures are point-in-time market estimates as of publication; forecast years are projections
Data Set(s) Format(s): PDF / Excel
Raw or scraped data: No — syndicated analyst research
Key Fields: Market size, CAGR, historical and forecast values, drug class, formulation, route of administration, distribution channel, application, regional and country analysis, company profiles, market share, competitive landscape, strategic developments, growth drivers, restraints, and investment opportunities
Number of companies/brands covered: 15
Key Data Points
- USD 2.76 billion — global Vascular Dementia (VaD) Drugs Market size in 2024.
- USD 2.9 billion — estimated global market size in 2025.
- USD 3.6 billion — projected market revenue in 2030.
- 4.3% — CAGR stated in the report.
- 28 countries — geographic coverage, with 15 companies profiled and market-share information available for 10 companies.
Additional Information Company Fact Sheet: nextmsc.com
Pricing Information
Customized purchase options are available for this report. Subscribers should inquire for applicable licensing and purchase options. Actual pricing is provided through the AWS Data Exchange offer.
Regulatory and Compliance Information
This report is built from aggregated, publicly available, and licensed secondary sources plus expert interviews conducted on an aggregated basis. It contains no individually identifiable personal data.
Subscription Verification
AWS Data Exchange requires subscription verification on all public offers (subscribers confirm they're not in a restricted country or a covered party).
Need Help?
For questions about this product, contact info@nextmsc.com .
About Your Company
Next Move Strategy Consulting (NextMSC) is a Boston-based market research and management consulting firm producing syndicated and custom research across healthcare and life sciences and other sectors, combining primary expert interviews with secondary research from proprietary databases. Its healthcare research covers pharmaceuticals, therapies, diagnostics, medical technologies, and related healthcare markets. Learn more at nextmsc.com
Highlights
- The global Vascular Dementia (VaD) Drugs Market was valued at USD 2.76 billion in 2024 and is estimated at USD 2.9 billion in 2025. The market is projected to reach USD 3.6 billion by 2030, with a 4.3% CAGR stated in the report, supported by rising dementia prevalence, cardiovascular disease incidence, and healthcare expenditure.
- The report provides detailed segmentation across drug class, formulation, route of administration, distribution channel, application, and region. Drug classes include cholinesterase inhibitors, NMDA receptor modulators, antiplatelets, anticoagulants, antihypertensives, and monoaminergic agents.
- The study covers 28 countries and profiles 15 companies, with market-share information available for 10 companies. It evaluates opportunities linked to neuroprotective drug development, clinical trials, emerging therapies, healthcare infrastructure, aging populations, and increasing demand for vascular dementia treatment options.
Details
Categories
Delivery method
Deployed on AWS
New
Introducing multi-product solutions
You can now purchase comprehensive solutions tailored to use cases and industries.
Features and programs
Financing for AWS Marketplace purchases
AWS Marketplace now accepts line of credit payments through the PNC Vendor Finance program. This program is available to select AWS customers in the US, excluding NV, NC, ND, TN, & VT.
Pricing
Custom pricing options
Pricing is based on your specific requirements and eligibility. Sign in to view any offers that have been extended to you.
Legal
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
Delivery details
AWS Data Exchange (ADX)
AWS Data Exchange is a service that helps AWS easily share and manage data entitlements from other organizations at scale.
Additional details
You will receive access to the following data sets.
Data set name | Type | Historical revisions | Future revisions | Sensitive information | Data dictionaries | Data samples |
|---|---|---|---|---|---|---|
NMSC_MarketResearch | All historical revisions | All future revisions | Not included | Not included |
Similar products
Access market sizing, forecasts, segmentation, regional analysis, competitive intelligence, and company profiles for the global Ovarian Cancer Drug Market, valued at USD 5.21 billion in 2025 and projected to reach USD 8.58 billion by 2030 at a CAGR of 10.50%.
Gain comprehensive insights into the global Detergent Market with historical analysis and forecasts through 2030. The market is valued at USD 159.49 billion in 2025 and is projected to reach USD 203.56 billion by 2030, growing at a CAGR of 5.0%.
Global Cigarette Market research with historical analysis (2020–2024) and forecasts through 2030, including market sizing, segmentation, competitive benchmarking, and regional analysis. The market is valued at USD 1,150.44 billion in 2025 and is projected to reach USD 1,263.59 billion by 2030 at a 1.9% CAGR.
Global Cigarette Market research with historical analysis (2020–2024) and forecasts through 2030, including market sizing, segmentation, competitive benchmarking, and regional analysis. The market is valued at USD 1,150.44 billion in 2025 and is projected to reach USD 1,263.59 billion by 2030 at a 1.9% CAGR.